Form 4: Labcorp Executive Akinbolade Oyegunwa Reports Stock Transactions
SEC Form 4 Filing
A Form 4 filing reveals Labcorp's EVP, CIO & CTO Akinbolade Oyegunwa's recent transactions involving restricted stock units and common stock.
Summary
- Akinbolade Oyegunwa, EVP, CIO & CTO of Labcorp Holdings Inc., filed a Form 4 detailing changes in beneficial ownership of company stock.
- On February 6, 2025, Oyegunwa vested 180 restricted stock units and acquired 180 shares of common stock.
- Also on February 6, 2025, 62 shares were disposed of to satisfy tax withholding obligations at a price of $247.74 per share.
- Following these transactions, Oyegunwa directly owns 2,784.253 shares of common stock.
- On February 7, 2025, Oyegunwa vested 149 restricted stock units and acquired 149 shares of common stock.
- Also on February 7, 2025, 51 shares were disposed of to satisfy tax withholding obligations at a price of $246.27 per share.
- Following these transactions, Oyegunwa directly owns 2,882.253 shares of common stock.
- Oyegunwa also holds 1,902 restricted stock units from a grant vesting in three equal annual installments beginning February 6, 2025, and 1,753 restricted stock units from a grant vesting in two equal installments beginning February 7, 2025.
Sentiment
Score: 5
Explanation: The document is a neutral regulatory filing, reflecting standard stock transactions. It doesn't inherently convey positive or negative sentiment.
Industry Context
This filing is a routine disclosure related to executive compensation and stock ownership, common in publicly traded companies like Labcorp. It provides transparency into the transactions of company insiders.
Stakeholder Impact
- The transactions have a minor impact on shareholders as they reflect routine executive compensation and stock ownership changes.
- The transactions have a minor impact on employees as they reflect routine executive compensation and stock ownership changes.
Key Dates
| Date | Description |
|---|---|
| 02/06/2025 | Vesting of 180 restricted stock units and acquisition of 180 common shares; disposal of 62 shares for tax obligations. |
| 02/07/2025 | Vesting of 149 restricted stock units and acquisition of 149 common shares; disposal of 51 shares for tax obligations. |
| 02/10/2025 | Date of signature for the Form 4 filing. |
Keywords
Form 4, beneficial ownership, restricted stock units, common stock, Labcorp, Oyegunwa, transactions, vesting
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.